Exact Mass: 768.3806212000001
Exact Mass Matches: 768.3806212000001
Found 100 metabolites which its exact mass value is equals to given mass value 768.3806212000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Deltorphin I
C37H52N8O10 (768.3806212000001)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Deltorphin I is a δ-opioid receptor agonist with high affinity and selectivity. Deltorphin I is a δ-opioid receptor agonist with high affinity and selectivity.
goniodomin A
Desacetylvinblastine
C44H56N4O8 (768.4097936000001)
Desacetylvinblastine is a metabolite of vinblastine. Vinblastine is an antimicrotubule drug used to treat certain kinds of cancer, including Hodgkins lymphoma, non-small cell lung cancer, breast cancer, head and neck cancer, and testicular cancer. It is also used to treat Langerhans cell histiocytosis. Vinblastine was traditionally obtained from Catharanthus roseus, also known as Vinca rosea, a Madagascar Periwinkle. It is generated in the plant by the joining of two alkaloids catharanthine and vindoline. (Wikipedia)
Polypodoside C
Polypodoside C belongs to the class of organic compounds known as steroidal glycosides. These are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. Polypodoside C is an extremely weak basic (essentially neutral) compound (based on its pKa). Polypodoside C is a constituent of the rhizomes of the licorice fern Polypodium glycyrrhiza. It is a natural sweetener. Constituent of the rhizomes of the licorice fern Polypodium glycyrrhiza. Natural sweetener, see above
Deacetylvinblastine
C44H56N4O8 (768.4097936000001)
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
4-Desacetylvinblastine hydrazide
12beta-hydroxycimigenol 3-O-beta-D-xylopyranosyl-(1->3)-beta-D-xylopyranoside|12beta-hydroxycimigenol-3-O-beta-D-xylopyranosyl-(1->3)-beta-D-xylopyranoside|cimifoside A
3beta-[beta-glucopyranosyl-(1->2)-beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione|pandaroside C
5alpha-4,5-dihydro-scillirosidin-3-O-alpha-L-rhamnosido-(1-4)-beta-D-glucoside
(3beta,23S,25R)-23-hydroxy-12-oxospirost-5-en-3-yl 4-O-beta-D-glucopyranosyl-beta-D-galactopyranoside|kingianoside I
(3beta,5alpha,11alpha,12beta,14beta)-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy}-8,12,14-trihydroxy-20-oxopregnan-11-yl (2E)-2-methylbut-2-enoate|tenacigenoside C
(3beta,5alpha,8alpha,17alpha,25R)-spirost-6-ene-5,8-epidioxy-3,17-diol 3-O-alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranoside|pariposide D
(24S,25R)-3beta,24-dihydroxy-spirostan-5-en-12-one-3-O-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranoside|kingianoside H
(25R,26R)-26-methoxyspirost-5-ene-3beta,17alpha-diol 3-O-2)-beta-D-glucopyranoside>
3-O-[alpha-L-arabinopyranosyl-(1->2)-beta-D-xylopyranosyl]-3beta,6alpha,23a,25-tetrahydroxy-16beta,24;20(R),24(S)-diepoxycycloartane
cherimolacyclopeptide G|cyclo(Pro-Gly-Ala-Val-Pro-Ile-Tyr-Ala)
Desacetylvinblastine
C44H56N4O8 (768.4097936000001)
D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids
OHODiA-PI
Parisvanioside D
Pariposide D
Pandaroside C
N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]
C42H52N6O8 (768.3846432000001)
[(E)-5-[hydroxy-[3-[5-[3-[hydroxy-[(Z)-5-hydroxy-3-methylpent-2-enoyl]amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]amino]-3-methyl-5-oxopent-3-enyl] 3-acetamido-5-[hydroxy-[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]pentanoate
C35H56N6O13 (768.3905166000001)
(3S,5S,9R,10R,13S,14S,17S)-17-[(1R)-1-[(2S,5R,6S)-6-[(2S,3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5-methyloxan-2-yl]ethyl]-17-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,5,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-6-one
2,2-dimethylpropanoic acid [(2S)-2-[(3S,9R,10R)-16-[[anilino(oxo)methyl]amino]-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-12-yl]propyl] ester
N-(2-aminophenyl)-4-[[[(3R,9R,10S)-16-[[(4-fluoroanilino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl-methylamino]methyl]benzamide
C43H53FN6O6 (768.4010410000001)
[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
2-(Acetylamino)-7-oxo-9-methyl-6,11-dihydroxy-6-aza-8-undecenoic acid 5-[[3-[5-[3-[(3-methyl-5-hydroxy-2-pentenoyl)(hydroxy)amino]propyl]-3,6-dioxopiperazine-2-yl]propyl](hydroxy)amino]-3-methyl-5-oxo-3-pentenyl ester
C35H56N6O13 (768.3905166000001)
[3,4,5-trihydroxy-6-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]oxan-2-yl]methanesulfonic acid
[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[5-[hydroxy-[3-[5-[3-[hydroxy-[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]amino]-3-methyl-5-oxopent-3-enyl] 2-acetamido-5-[hydroxy-[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]pentanoate
C35H56N6O13 (768.3905166000001)
[(2S,3S,6S)-6-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[(2S,3S,6S)-6-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
[(2S,3S,6S)-6-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid
1-{14,15-bis[(3,4-dicarboxybutanoyl)oxy]-3-hydroxy-12,16-dimethylicosan-2-yl}-3-hydroxypyridin-1-ium
[C39H62NO14]+ (768.4170091999999)
methyl (1r,9r,10s,11r,12r,19r)-12-ethyl-4-[(13s,15r,17s)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-13-yl]-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
C44H56N4O8 (768.4097936000001)
(1r,3ar,3bs,5r,5as,7s,9as,9br,11ar)-7-{[(2r,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b-dihydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate
(3r)-7-{4'-[(1r,3r)-6,8-dihydroxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-1,1'-dihydroxy-8,8'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalen]-4-yl}-8-methoxy-1,3-dimethyl-3,4-dihydro-2h-isoquinolin-6-one
C47H48N2O8 (768.3410488000001)
1-[(3as,3br,7s,9ar,9bs,11as)-7-{[(2r,3r,4s,5s,6r)-4-hydroxy-6-(hydroxymethyl)-3,5-bis({[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})oxan-2-yl]oxy}-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone
(1s,3s)-5-{1,1'-dihydroxy-4'-[(3r)-6-hydroxy-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-5-yl]-8,8'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalen]-4-yl}-1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol
C47H48N2O8 (768.3410488000001)
(3r)-5-{4'-[(1r,3r)-6,8-dihydroxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-1,1'-dihydroxy-8,8'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalen]-4-yl}-8-methoxy-1,3-dimethyl-3,4-dihydro-2h-isoquinolin-6-one
C47H48N2O8 (768.3410488000001)
n-(6-benzyl-5,14-dihydroxy-15-isopropyl-3,7,9,10,12,16,19-heptamethyl-2,8,11,17-tetraoxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,13-dien-18-yl)-4,4-dichloro-n,3-dimethylbutanamide
C36H54Cl2N6O8 (768.3379984000001)